BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
6.72
-0.09 (-1.32%)
At close: Oct 16, 2025, 3:59 PM
6.70
-0.29%
After-hours: Oct 16, 2025, 07:42 PM EDT
-1.32% (1D)
| Bid | 6.68 |
| Market Cap | 1.41B |
| Revenue (ttm) | 557.51M |
| Net Income (ttm) | -35.71M |
| EPS (ttm) | -0.18 |
| PE Ratio (ttm) | -37.33 |
| Forward PE | 11.89 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 6.86 |
| Volume | 9,981,776 |
| Avg. Volume (20D) | 3,802,851 |
| Open | 6.87 |
| Previous Close | 6.81 |
| Day's Range | 6.70 - 6.92 |
| 52-Week Range | 6.00 - 11.31 |
| Beta | 1.04 |
| Ex-Dividend Date | n/a |
About BCRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBioCryst Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 3, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+9.81%
BioCryst Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
5 months ago
+23.52%
BioCryst Pharmaceuticals shares are trading higher after the company reported a Q1 sales beat.
